FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015382344> ?p ?o ?g. }

• W2015382344 endingPage "1490" @default.
• W2015382344 startingPage "1486" @default.
• W2015382344 abstract "In the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study, 522 patients were randomized to either rate or rhythm control therapy. Lone atrial fibrillation (AF) was present in 89 patients. Demographics, cardiovascular mortality and morbidity, and quality of life were compared between patients with lone AF and those with underlying structural heart disease. Patients with lone AF were significantly younger (65 ± 10 vs 69 ± 8 years) and had fewer complaints of fatigue (p = 0.01) and dyspnea (p = 0.005). With lone AF, quality-of-life scores were higher on almost all 8 Medical Outcomes Study Short-Form health survey questionnaire subscales, and comparable to healthy, age- and gender-matched controls. Mean follow-up was 2.3 ± 0.6 years. Cardiovascular end points occurred in 9 patients with lone AF (10%), consisting of death (all bleedings) 3%, thromboembolic complications in 3%, nonfatal bleeding in 2%, and pacemaker implantation in 2%, but no heart failure and severe adverse effects due to antiarrhythmic drugs occurred. End points occurred in 95 patients (22%) with underlying diseases. Heart failure and severe adverse effects from drugs did not occur in patients with lone AF in this study. Despite the absence of demonstrable cardiovascular and cerebrovascular disease, lone AF is associated with bleeding and thromboembolism. In the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study, 522 patients were randomized to either rate or rhythm control therapy. Lone atrial fibrillation (AF) was present in 89 patients. Demographics, cardiovascular mortality and morbidity, and quality of life were compared between patients with lone AF and those with underlying structural heart disease. Patients with lone AF were significantly younger (65 ± 10 vs 69 ± 8 years) and had fewer complaints of fatigue (p = 0.01) and dyspnea (p = 0.005). With lone AF, quality-of-life scores were higher on almost all 8 Medical Outcomes Study Short-Form health survey questionnaire subscales, and comparable to healthy, age- and gender-matched controls. Mean follow-up was 2.3 ± 0.6 years. Cardiovascular end points occurred in 9 patients with lone AF (10%), consisting of death (all bleedings) 3%, thromboembolic complications in 3%, nonfatal bleeding in 2%, and pacemaker implantation in 2%, but no heart failure and severe adverse effects due to antiarrhythmic drugs occurred. End points occurred in 95 patients (22%) with underlying diseases. Heart failure and severe adverse effects from drugs did not occur in patients with lone AF in this study. Despite the absence of demonstrable cardiovascular and cerebrovascular disease, lone AF is associated with bleeding and thromboembolism." @default.
• W2015382344 created "2016-06-24" @default.
• W2015382344 creator A5003578699 @default.
• W2015382344 creator A5005773814 @default.
• W2015382344 creator A5038161365 @default.
• W2015382344 creator A5045583556 @default.
• W2015382344 creator A5049123888 @default.
• W2015382344 creator A5051480491 @default.
• W2015382344 creator A5055872647 @default.
• W2015382344 creator A5064509705 @default.
• W2015382344 creator A5069496306 @default.
• W2015382344 creator A5090763481 @default.
• W2015382344 date "2004-12-01" @default.
• W2015382344 modified "2023-09-25" @default.
• W2015382344 title "Clinical characteristics of persistent lone atrial fibrillation in the RACE study" @default.
• W2015382344 cites W1519386588 @default.
• W2015382344 cites W1738640266 @default.
• W2015382344 cites W1965224237 @default.
• W2015382344 cites W1969547123 @default.
• W2015382344 cites W1988128773 @default.
• W2015382344 cites W1988899558 @default.
• W2015382344 cites W1994231358 @default.
• W2015382344 cites W1996486107 @default.
• W2015382344 cites W2002103303 @default.
• W2015382344 cites W2002107072 @default.
• W2015382344 cites W2003455595 @default.
• W2015382344 cites W2028843696 @default.
• W2015382344 cites W2038042463 @default.
• W2015382344 cites W2040051636 @default.
• W2015382344 cites W2053535889 @default.
• W2015382344 cites W2091000151 @default.
• W2015382344 cites W2100922457 @default.
• W2015382344 cites W2110253 @default.
• W2015382344 cites W2124805101 @default.
• W2015382344 cites W2151074096 @default.
• W2015382344 cites W2340349481 @default.
• W2015382344 cites W4211174769 @default.
• W2015382344 cites W4255962172 @default.
• W2015382344 doi "https://doi.org/10.1016/j.amjcard.2004.08.024" @default.
• W2015382344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15589001" @default.
• W2015382344 hasPublicationYear "2004" @default.
• W2015382344 type Work @default.
• W2015382344 sameAs 2015382344 @default.
• W2015382344 citedByCount "22" @default.
• W2015382344 countsByYear W20153823442012 @default.
• W2015382344 countsByYear W20153823442013 @default.
• W2015382344 countsByYear W20153823442014 @default.
• W2015382344 countsByYear W20153823442015 @default.
• W2015382344 countsByYear W20153823442016 @default.
• W2015382344 countsByYear W20153823442017 @default.
• W2015382344 countsByYear W20153823442019 @default.
• W2015382344 countsByYear W20153823442020 @default.
• W2015382344 countsByYear W20153823442022 @default.
• W2015382344 crossrefType "journal-article" @default.
• W2015382344 hasAuthorship W2015382344A5003578699 @default.
• W2015382344 hasAuthorship W2015382344A5005773814 @default.
• W2015382344 hasAuthorship W2015382344A5038161365 @default.
• W2015382344 hasAuthorship W2015382344A5045583556 @default.
• W2015382344 hasAuthorship W2015382344A5049123888 @default.
• W2015382344 hasAuthorship W2015382344A5051480491 @default.
• W2015382344 hasAuthorship W2015382344A5055872647 @default.
• W2015382344 hasAuthorship W2015382344A5064509705 @default.
• W2015382344 hasAuthorship W2015382344A5069496306 @default.
• W2015382344 hasAuthorship W2015382344A5090763481 @default.
• W2015382344 hasConcept C126322002 @default.
• W2015382344 hasConcept C159110408 @default.
• W2015382344 hasConcept C164705383 @default.
• W2015382344 hasConcept C2775914520 @default.
• W2015382344 hasConcept C2777289489 @default.
• W2015382344 hasConcept C2778198053 @default.
• W2015382344 hasConcept C2779161974 @default.
• W2015382344 hasConcept C2779951463 @default.
• W2015382344 hasConcept C2780074459 @default.
• W2015382344 hasConcept C71924100 @default.
• W2015382344 hasConceptScore W2015382344C126322002 @default.
• W2015382344 hasConceptScore W2015382344C159110408 @default.
• W2015382344 hasConceptScore W2015382344C164705383 @default.
• W2015382344 hasConceptScore W2015382344C2775914520 @default.
• W2015382344 hasConceptScore W2015382344C2777289489 @default.
• W2015382344 hasConceptScore W2015382344C2778198053 @default.
• W2015382344 hasConceptScore W2015382344C2779161974 @default.
• W2015382344 hasConceptScore W2015382344C2779951463 @default.
• W2015382344 hasConceptScore W2015382344C2780074459 @default.
• W2015382344 hasConceptScore W2015382344C71924100 @default.
• W2015382344 hasIssue "12" @default.
• W2015382344 hasLocation W20153823441 @default.
• W2015382344 hasLocation W20153823442 @default.
• W2015382344 hasOpenAccess W2015382344 @default.
• W2015382344 hasPrimaryLocation W20153823441 @default.
• W2015382344 hasRelatedWork W1972651039 @default.
• W2015382344 hasRelatedWork W1974061424 @default.
• W2015382344 hasRelatedWork W2022000083 @default.
• W2015382344 hasRelatedWork W2051283358 @default.
• W2015382344 hasRelatedWork W2073453392 @default.
• W2015382344 hasRelatedWork W2317055961 @default.
• W2015382344 hasRelatedWork W2364196197 @default.
• W2015382344 hasRelatedWork W2373898166 @default.
• W2015382344 hasRelatedWork W2919782842 @default.

• next